ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Stock Fundamental Analysis
Europe - OSL:AZT - NO0010014632 - Common Stock
24.05 NOK
-0.05 (-0.21%)
Taking everything into account, AZT scores 5 out of 10 in our fundamental rating. AZT was compared to 74 industry peers in the Biotechnology industry. While AZT has a great health rating, its profitability is only average at the moment. AZT is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AZT had positive earnings in the past year.
AZT had a positive operating cash flow in the past year.
Each year in the past 5 years AZT has been profitable.
AZT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
AZT has a Return On Assets of 0.80%. This is in the better half of the industry: AZT outperforms 72.97% of its industry peers.
With a decent Return On Equity value of 0.86%, AZT is doing good in the industry, outperforming 77.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.8% | ||
| ROE | 0.86% | ||
| ROIC | N/A |
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AZT's Profit Margin of 2.86% is fine compared to the rest of the industry. AZT outperforms 78.38% of its industry peers.
AZT's Profit Margin has declined in the last couple of years.
With an excellent Gross Margin value of 94.85%, AZT belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
In the last couple of years the Gross Margin of AZT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 2.86% | ||
| GM | 94.85% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
AZT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AZT has been increased compared to 1 year ago.
The number of shares outstanding for AZT has been increased compared to 5 years ago.
The debt/assets ratio for AZT has been reduced compared to a year ago.
2.2 Solvency
AZT has an Altman-Z score of 33.49. This indicates that AZT is financially healthy and has little risk of bankruptcy at the moment.
AZT has a Altman-Z score of 33.49. This is amongst the best in the industry. AZT outperforms 100.00% of its industry peers.
AZT has a debt to FCF ratio of 1.29. This is a very positive value and a sign of high solvency as it would only need 1.29 years to pay back of all of its debts.
AZT's Debt to FCF ratio of 1.29 is amongst the best of the industry. AZT outperforms 89.19% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that AZT is not too dependend on debt financing.
The Debt to Equity ratio of AZT (0.01) is better than 75.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 1.29 | ||
| Altman-Z | 33.49 |
ROIC/WACCN/A
WACC8.52%
2.3 Liquidity
A Current Ratio of 15.90 indicates that AZT has no problem at all paying its short term obligations.
AZT has a better Current ratio (15.90) than 97.30% of its industry peers.
A Quick Ratio of 15.02 indicates that AZT has no problem at all paying its short term obligations.
AZT has a better Quick ratio (15.02) than 95.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 15.9 | ||
| Quick Ratio | 15.02 |
3. Growth
3.1 Past
The earnings per share for AZT have decreased strongly by -88.89% in the last year.
The earnings per share for AZT have been decreasing by -43.42% on average. This is quite bad
The Revenue for AZT has decreased by -15.64% in the past year. This is quite bad
AZT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.22% yearly.
EPS 1Y (TTM)-88.89%
EPS 3Y-43.42%
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-6.57%
Revenue growth 5Y18.22%
Sales Q2Q%0.96%
3.2 Future
AZT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.16% yearly.
The Revenue is expected to grow by 18.45% on average over the next years. This is quite good.
EPS Next Y1%
EPS Next 2Y77.15%
EPS Next 3Y71.16%
EPS Next 5YN/A
Revenue Next Year7.51%
Revenue Next 2Y16.08%
Revenue Next 3Y16.64%
Revenue Next 5Y18.45%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 801.67, AZT can be considered very expensive at the moment.
AZT's Price/Earnings ratio is a bit cheaper when compared to the industry. AZT is cheaper than 74.32% of the companies in the same industry.
AZT is valuated expensively when we compare the Price/Earnings ratio to 26.34, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 54.74, the valuation of AZT can be described as expensive.
Based on the Price/Forward Earnings ratio, AZT is valued a bit cheaper than 79.73% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AZT to the average of the S&P500 Index (34.43), we can say AZT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 801.67 | ||
| Fwd PE | 54.74 |
4.2 Price Multiples
70.27% of the companies in the same industry are more expensive than AZT, based on the Enterprise Value to EBITDA ratio.
AZT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AZT is cheaper than 77.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 223.52 | ||
| EV/EBITDA | 2155.43 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AZT does not grow enough to justify the current Price/Earnings ratio.
AZT's earnings are expected to grow with 71.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)801.67
PEG (5Y)N/A
EPS Next 2Y77.15%
EPS Next 3Y71.16%
5. Dividend
5.1 Amount
No dividends for AZT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OSL:AZT (11/13/2025, 11:15:30 AM)
24.05
-0.05 (-0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners16.46%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap1.23B
Revenue(TTM)97.87M
Net Income(TTM)2.80M
Analysts76.67
Price Target34.68 (44.2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-36.35%
Min EPS beat(2)-269.73%
Max EPS beat(2)197.03%
EPS beat(4)2
Avg EPS beat(4)268.95%
Min EPS beat(4)-269.73%
Max EPS beat(4)1288.12%
EPS beat(8)3
Avg EPS beat(8)136.16%
EPS beat(12)4
Avg EPS beat(12)79.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.61%
Min Revenue beat(2)-13.1%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-6.89%
Min Revenue beat(4)-18.99%
Max Revenue beat(4)2.64%
Revenue beat(8)3
Avg Revenue beat(8)-5.33%
Revenue beat(12)3
Avg Revenue beat(12)-6.56%
Revenue beat(16)6
Avg Revenue beat(16)-2.7%
PT rev (1m)21.43%
PT rev (3m)78.95%
EPS NQ rev (1m)-33.33%
EPS NQ rev (3m)-20%
EPS NY rev (1m)-3.45%
EPS NY rev (3m)-20%
Revenue NQ rev (1m)-4.76%
Revenue NQ rev (3m)5.26%
Revenue NY rev (1m)-2.13%
Revenue NY rev (3m)3.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 801.67 | ||
| Fwd PE | 54.74 | ||
| P/S | 12.55 | ||
| P/FCF | 223.52 | ||
| P/OCF | 116.42 | ||
| P/B | 3.76 | ||
| P/tB | 4.2 | ||
| EV/EBITDA | 2155.43 |
EPS(TTM)0.03
EY0.12%
EPS(NY)0.44
Fwd EY1.83%
FCF(TTM)0.11
FCFY0.45%
OCF(TTM)0.21
OCFY0.86%
SpS1.92
BVpS6.39
TBVpS5.72
PEG (NY)801.67
PEG (5Y)N/A
Graham Number2.08
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.8% | ||
| ROE | 0.86% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 2.86% | ||
| GM | 94.85% | ||
| FCFM | 5.61% |
ROA(3y)6.16%
ROA(5y)14.45%
ROE(3y)6.81%
ROE(5y)16.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-39.27%
PM growth 5YN/A
GM growth 3Y-0.94%
GM growth 5Y-0.64%
F-Score5
Asset Turnover0.28
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 1.29 | ||
| Debt/EBITDA | 10.86 | ||
| Cap/Depr | 62.51% | ||
| Cap/Sales | 5.16% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 2482.35% | ||
| Profit Quality | 195.97% | ||
| Current Ratio | 15.9 | ||
| Quick Ratio | 15.02 | ||
| Altman-Z | 33.49 |
F-Score5
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)231.16%
Cap/Depr(5y)215.23%
Cap/Sales(3y)11.45%
Cap/Sales(5y)9.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-88.89%
EPS 3Y-43.42%
EPS 5YN/A
EPS Q2Q%20%
EPS Next Y1%
EPS Next 2Y77.15%
EPS Next 3Y71.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.64%
Revenue growth 3Y-6.57%
Revenue growth 5Y18.22%
Sales Q2Q%0.96%
Revenue Next Year7.51%
Revenue Next 2Y16.08%
Revenue Next 3Y16.64%
Revenue Next 5Y18.45%
EBIT growth 1Y-196.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year357.14%
EBIT Next 3Y146.62%
EBIT Next 5YN/A
FCF growth 1Y-33.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.1%
OCF growth 3Y-71.92%
OCF growth 5Y-16%
ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ
What is the ChartMill fundamental rating of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL.
Can you provide the valuation status for ARCTICZYMES TECHNOLOGIES ASA?
ChartMill assigns a valuation rating of 4 / 10 to ARCTICZYMES TECHNOLOGIES ASA (AZT.OL). This can be considered as Fairly Valued.
What is the profitability of AZT stock?
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for AZT stock?
The Earnings per Share (EPS) of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is expected to grow by 1% in the next year.